BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF), a pioneer in Botanical Synthesis technology, will participate in the H.C. Wainwright 26th Annual Global Investment Conference on September 9-10, 2024, in New York City. CEO Ilan Sobel will conduct 1-on-1 meetings with institutional investors and deliver a company presentation on Monday, September 9, at 2:30 p.m. Eastern time.
The presentation will be available for live streaming and on-demand viewing via webcast. In-person attendance is by invitation only. Interested parties can contact H.C. Wainwright representatives or email BHSC@mzgroup.us to schedule meetings with BioHarvest management.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF), un pioniere nella tecnologia di Sintesi Botanica, parteciperà al 26° Conferenza Annuale Globale sugli Investimenti di H.C. Wainwright che si terrà il 9-10 settembre 2024 a New York City. Il CEO Ilan Sobel condurrà incontri individuali con investitori istituzionali e presenterà la società lunedì 9 settembre, alle 14:30 ora orientale.
La presentazione sarà disponibile per streaming dal vivo e visione su richiesta tramite webcast. La partecipazione di persona è solo su invito. Le parti interessate possono contattare i rappresentanti di H.C. Wainwright o inviare un'email a BHSC@mzgroup.us per programmare incontri con la direzione di BioHarvest.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF), un pionero en tecnología de Síntesis Botánica, participará en la 26ª Conferencia Anual Global de Inversiones de H.C. Wainwright que se llevará a cabo el 9-10 de septiembre de 2024 en Nueva York. El CEO Ilan Sobel realizará reuniones individuales con inversores institucionales y presentará la empresa el lunes 9 de septiembre a las 2:30 p.m. hora del Este.
La presentación estará disponible para transmisión en vivo y visualización bajo demanda a través de webcast. La asistencia en persona es solo por invitación. Las partes interesadas pueden contactar a los representantes de H.C. Wainwright o enviar un correo electrónico a BHSC@mzgroup.us para programar reuniones con la dirección de BioHarvest.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF), 식물 합성 기술의 선구자, H.C. Wainwright 제26회 연례 글로벌 투자 컨퍼런스에 2024년 9월 9-10일 뉴욕에서 참여할 예정입니다. CEO 이란 소벨(Ilan Sobel)은 기관 투자자들과의 1:1 회의를 진행하고, 9월 9일 월요일 동부 표준시 기준 오후 2시 30분에 회사 발표를 할 것입니다.
발표는 실시간 스트리밍 및 주문형 보기를 통해 제공됩니다. 현장 참석은 초대받은 사람만 가능합니다. 관심 있는 분들은 H.C. Wainwright의 대표에게 연락하거나 BHSC@mzgroup.us로 이메일을 보내 BioHarvest 경영진과의 회의를 예약할 수 있습니다.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF), un pionnier dans la technologie de synthèse botanique, participera à la 26ème Conférence Annuelle Mondiale sur les Investissements de H.C. Wainwright qui se déroulera les 9 et 10 septembre 2024 à New York. Le PDG Ilan Sobel mènera des réunions individuelles avec des investisseurs institutionnels et présentera l'entreprise le lundi 9 septembre à 14h30, heure de l'Est.
La présentation sera disponible en streaming en direct et en visionnage à la demande via webcast. La participation en personne est uniquement sur invitation. Les parties intéressées peuvent contacter les représentants de H.C. Wainwright ou envoyer un e-mail à BHSC@mzgroup.us pour planifier des réunions avec la direction de BioHarvest.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF), ein Pionier in der botanischen Synthesetechnologie, wird an der 26. jährlichen globalen Investorenkonferenz von H.C. Wainwright am 9. und 10. September 2024 in New York City teilnehmen. CEO Ilan Sobel wird Einzelgespräche mit institutionellen Investoren führen und am Montag, den 9. September um 14:30 Uhr Eastern Time eine Unternehmenspräsentation halten.
Die Präsentation wird für Live-Streaming und On-Demand-Viewing über Webcast zur Verfügung stehen. Die persönliche Teilnahme ist nur auf Einladung möglich. Interessierte Parteien können die Vertreter von H.C. Wainwright kontaktieren oder eine E-Mail an BHSC@mzgroup.us senden, um Meetings mit dem Management von BioHarvest zu planen.
- None.
- None.
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 4, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced it will participate in the H.C. Wainwright 26th Annual Global Investment Conference taking place September 9 - 10, 2024 at the Lotte New York Palace Hotel in New York City.
Ilan Sobel, CEO of BioHarvest Sciences, will conduct 1x1 meetings with institutional investors throughout the conference, and deliver the Company's presentation, which can be streamed live or viewed on-demand by the public at the webcast link below.
H.C. Wainwright 26th Annual Global Investment Conference
Date: Monday, September 9, 2024
Presentation Time: 2:30 p.m. Eastern time
Webcast: https://journey.ct.events/view/4039aa22-119c-4dfb-9525-1e0c48bc4a2b
Location: Lotte New York Palace Hotel, New York City
In-person attendance is by invitation only and registration is required for conference participation. For more information on the H.C. Wainwright 26th Annual Global Investment Conference, or to schedule a meeting with BioHarvest management, please contact your H.C. Wainwright representative or email your request to BHSC@mzgroup.us.
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) (FSE: 8MV) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based molecules, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit www.bioharvest.com.
Forward-Looking Statements
Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.
Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.
This release has been reviewed and approved by Dave Ryan, VP Investor Relations, who accepts responsibilities for its contents.
BioHarvest Corporate Contact:
Dave Ryan, VP Investor Relations & Director
+1 (604) 622-1186
info@bioharvest.com
Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
+1 (949) 259-4987
BHSC@mzgroup.us
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/222090
FAQ
When is BioHarvest Sciences (CNVCF) presenting at the H.C. Wainwright Global Investment Conference?
Where can I watch BioHarvest Sciences' (CNVCF) presentation at the H.C. Wainwright conference?
How can investors meet with BioHarvest Sciences (CNVCF) management at the H.C. Wainwright conference?
What is the location of the H.C. Wainwright conference where BioHarvest Sciences (CNVCF) is presenting?
